- Systematic review and meta-analysis of five placebo-controlled RCTs (335 participants) testing perioperative pregabalin in adults undergoing elective lumbar spine surgery.
- Pregabalin was compared with placebo, with the primary outcome being pain intensity at 3 months, pooled across four trials (275 participants).
- Pregabalin did not reduce 3-month pain intensity (SMD 0.03, 95% CI -0.41 to 0.47; I² 69%; low certainty).
- Functional disability was lower with pregabalin (SMD -0.51, 95% CI -0.86 to -0.16), but the differences fell below minimal important change thresholds, with very low certainty.
Neuro
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- A Bayesian systematic review and meta-analysis of 54 studies, including 367,896 critically ill adults, examined new-onset atrial fibrillation in general ICUs and high-dependency units.
- It compared post-discharge systemic thromboembolism in patients with and without new-onset atrial fibrillation, with follow-up ranging from 1.5 months to 5 years.
- Pooled NOAF incidence was 10.6% (95% CrI 8.6-12.9%), and post-discharge thromboembolism risk was 7.1% (95% CrI 4.5-11.0%). Relative risk was 1.94 (95% CrI 1.23-3.29) across six studies, rising to 2.01 with adjustment.
- Anticoagulation use was low, at 32.9% in-hospital and 35.9% post-discharge, and 23.9% of patients with NOAF were later diagnosed with atrial fibrillation.
- Systematic review and meta-analysis of seven retrospective cohorts (28,525 patients) comparing lumbar fusion patients with and without preoperative GLP-1RA exposure.
- Six of the seven studies used propensity score matching or another matching strategy to balance the comparison groups.
- No significant association with reoperation or revision (OR 0.74, 95% CI 0.44-1.24; P = 0.25) or postoperative infection (OR 0.83, 95% CI 0.68-1.00; P = 0.05).
- The authors found no signal of increased postoperative risk and called for prospective studies with standardized exposure definitions and perioperative management protocols.
- Meta-analysis of 25 randomized controlled trials (3344 patients) comparing perioperative ketamine or esketamine with placebo or standard care for postoperative delirium.
- Ketamine (9 trials) and esketamine (16 trials) were compared with control, with subgroup analyses by dose, regimen, surgery type and timing of assessment.
- Both agents reduced postoperative delirium risk: ketamine RR 0.69 (95% CI 0.49-0.98, P = .04) and esketamine RR 0.58 (95% CI 0.36-0.95, P = .03).
- Dizziness risk rose (RR 1.45, 95% CI 1.14-1.84), and trial sequential analysis found the evidence inconclusive, so the authors call for large multicenter RCTs.
- Systematic review and meta-analysis of 13 randomized trials including 3,861 adult ICU patients, comparing open or flexible family visiting with restricted visiting.
- Delirium was the primary outcome; secondary outcomes were invasive ventilation duration, ICU length of stay, hospital-acquired infections, and ICU mortality.
- Open or flexible presence reduced delirium (RR 0.48; 95% CI 0.29-0.81; low certainty) and invasive ventilation duration (MD -0.36 d; 95% CI -0.46 to -0.26 d; low certainty).
- No effect was seen on ICU length of stay, infections, or ICU mortality; the authors note low certainty of evidence and substantial heterogeneity.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
- Systematic review and meta-analysis of 21 randomized controlled trials including 1271 adults undergoing spinal surgery.
- The exposure was perioperative intravenous magnesium sulfate, with a control group for comparison.
- Magnesium reduced 24-hour pain scores (MD -0.55, 95% CI -1.01 to -0.10, P = 0.02) and opioid consumption (MD -4.95 mg, 95% CI -8.74 to -1.15 mg, P = 0.01).
- Magnesium was associated with less postoperative nausea and vomiting but more hypotension, and with prolonged time to follow commands and recover orientation.